Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

National Institutes of Health

This source publishes only summary fields for this notice. Open the official notice for the full scope of work.

Deadline

7 Jan 2027(79 days left)

Published

18 Nov 2024(23 months ago)

Contract value

Not published

Location

United States

Reference

357203

First seen

2 hours ago